-+ 0.00%
-+ 0.00%
-+ 0.00%

Nektar Therapeutics Enters Quiet Period Beginning September 8 Until Public Announcement Of Data From 24-Week Off Treatment Follow-Up Period Of Phase 2b REZOLVE-AA Study Of Rezpegaldesleukin In Patients With Alopecia Areata

Benzinga·09/08/2026 20:35:18
Listen to the news

-SEC Filing